Pierre‐Michel Llorca

Author

Also Known As

Andrei Szöke, C. Liling, James B. Kirkbride, Llorca, PM, Llorca, Pierre Michel, Llorca, Pierre-Michel, Marie-Odile Krebs, P M LLorca, P M Llorca, P-M Llorca

676

Publications

12.3K

Citations

H-Index

206

Concepts

All Affiliations

Inserm Université Clermont Auvergne Centre Hospitalier Universitaire de Clermont-Ferrand Fondation FondaMental Assistance Publique – Hôpitaux de Paris

About

Pierre‐Michel Llorca is an author at Inserm specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	86	2.8K
2	Health Sciences	4	4	87
3	Language Studies	1	1	30
4	Natural Sciences	1	1	16
5	Nursing	1	1	24

Pierre‐Michel Llorca

191

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study Hannah E. Jongsma, Charlotte Gayer‐Anderson, Antonio Lasalvia, JAMA Psychiatry	2017	323
Treatment of Schizophrenia With Long-Acting Injectable Risperidone W. Wolfgang Fleischhacker, Mariëlle Eerdekens, Keith Karcher, The Journal of Clinical Psychiatry	2003	287
Diagnostic criteria for apathy in clinical practice Emmanuel Mulin, Elsa Leone, Kathy Dujardin, International Journal of Geriatric Psychiatry	2010	215
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness Pierre‐Michel Llorca, Mocrane Abbar, Philippe Courtet, BMC Psychiatry	2013	178
Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Philippe P Derost, Lemlih Ouchchane, Dominique Morand, Neurology	2007	160
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression Andreas Reif, István Bitter, Jozefien Buyze, New England Journal of Medicine	2023	155
Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial Mocrane Abbar, Christophe Dematteï, Wissam El‐Hage, BMJ	2022	153
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder Pierre‐Michel Llorca, C. Spadone, Olivier Sol, The Journal of Clinical Psychiatry	2002	137
The “Functional Remission of General Schizophrenia” (FROGS) scale: Development and validation of a new questionnaire Pierre‐Michel Llorca, Christophe Lançon, Sylvie Lancrenon, Schizophrenia Research General Schizophrenia ”PsychopathologyPsychiatryPsychotic Disorder“ Functional Remission	2009	133
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies Hans-J rgen M ller, Pierre‐Michel Llorca, Emilio Sacchetti, International Clinical Psychopharmacology	2005	116

Page 1